Hellwig K, Koren G, Butzkueven H, Tilson H, Hernández-Diaz S, MacDonald T, Kornyeyeva E, Plana E, Lu Y, Cremer M, Amar RK, Schlosshauer R, Collins W, Geissbühler Y, Karlsson G. Cumulative data on pregnancy outcomes after exposure to fingolimod. Presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS); October 2013. Copenhagen, Denmark. Previously presented at the 18th Annual Conference of Rehabilitation in MS (RIMS).
Hellwig K, Koren G, Butzkueven H, Tilson H, Hernández-Diaz S, MacDonald T, Kornyeyeva E, Plana E, Lu Y, Cremer M, Amar RK, Schlosshauer R, Collins W, Geissbühler Y, Karlsson G. Cumulative data on pregnancy outcomes after exposure to fingolimod. Presented at the 18th Annual Conference of Rehabilitation in MS (RIMS); October 2013. Copenhagen, Denmark.
Caldero M, Pena M, Sanchez V, Quesada A, Mollo A, Marsal JR, Llovet R, Llarden M, Falguera M, Rodriguez A. Is good cholesterol linked to kidney function? Presented at the Metabolic Syndrome, Type II Diabetes and Atherosclerosis Congress; May 2009. Berlin, Germany.
Caldero M, Sanchez V, Quesada A, Pena M, Falguera M, Rodiguez A, Pascial G, Mollo A, Lafarga A, Marsal JR. Epidemiology of metabolic syndrome in Lleida (Spain). Presented at the Metabolic Syndrome, Type II Diabetes and Atherosclerosis Congress; May 2009. Berlin, Germany.